Gene Expression Literature Detail
|
Symbol Name ID |
Sox9
SRY (sex determining region Y)-box 9 MGI:98371 |
|
Reference
|
J:149544 Moniot B, Declosmenil F, Barrionuevo F, Scherer G, Aritake K, Malki S, Marzi L, Cohen-Solal A, Georg I, Klattig J, Englert C, Kim Y, Capel B, Eguchi N, Urade Y, Boizet-Bonhoure B, Poulat F, The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation. Development. 2009 Jun;136(11):1813-21 |
Indicates gene expression was analyzed but not necessarily detected.
| Age | E11.5 | E12 | E12.5 | E13.5 | E14.5 | E15.5 | E17.5 | P |
| Immunohistochemistry (section) | |
|
|
|
|
|
|
|
| In situ RNA (section) | ||||||||
| Immunohistochemistry (whole mount) | ||||||||
| In situ RNA (whole mount) | ||||||||
| In situ reporter (knock in) | ||||||||
| Northern blot | ||||||||
| Western blot | |
|||||||
| RT-PCR | |
|
|
|||||
| cDNA clones | ||||||||
| RNase protection | ||||||||
| Nuclease S1 | ||||||||
| Primer Extension |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|
|
||
Analysis Tools